Catalyst Pharmaceutical Inc. (CPRX) Financials
Key financial figures for Catalyst Pharmaceutical Inc. (Q1 2026).
Catalyst Pharmaceuticals reported revenue of $149.4 million for Q1 FY2026, up 5.6% from the same period a year earlier. Net income was $63.7 million, or $0.50 per share. Operating margin came to 49.02%, against 44.81% a year earlier. Free cash flow for the period was $59.6 million. Across the last 5 reported quarters, quarterly revenue has risen from $141.4 million in Q1 FY2025 to $149.4 million in Q1 FY2026. The figures above are as filed, and the full income statement, balance sheet and cash flow history for Catalyst Pharmaceuticals are on the SentiSense financials page.
- Revenue
- $149M
- Net Income
- $64M
- EPS
- $0.52
- Total Assets
- $1.1B
- Operating Cash Flow
- $60M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q1 FY2026 | $149M | $64M | $0.50 | 49.02% | $60M |
| Q4 FY2025 | $153M | $53M | $0.40 | 40.52% | $45M |
| Q3 FY2025 | $148M | $53M | $0.42 | 44.66% | $32M |
| Q2 FY2025 | $147M | $52M | $0.41 | 45.24% | $71M |
| Q1 FY2025 | $141M | $57M | $0.45 | 44.81% | $60M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $589M | $214M | $1.68 | 43.77% | $209M |
| FY2024 | $492M | $164M | $1.31 | 39.68% | $239M |
| FY2023 | $398M | $71M | $0.63 | 21.8% | $62M |
Frequently asked questions
What was Catalyst Pharmaceuticals's revenue last quarter?
Catalyst Pharmaceuticals reported revenue of $149.4 million for Q1 FY2026, up 5.6% from the same period a year earlier.
Is Catalyst Pharmaceuticals profitable?
Yes. Catalyst Pharmaceuticals reported net income of $63.7 million for Q1 FY2026, a net margin of 42.66% on revenue.
How has Catalyst Pharmaceuticals's margin trended?
Operating margin was 49.02% in Q1 FY2026, compared with 44.81% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did Catalyst Pharmaceuticals generate?
Catalyst Pharmaceuticals generated free cash flow of $59.6 million in Q1 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for Catalyst Pharmaceutical Inc. on SentiSense, with up to forty quarters and twenty fiscal years of history.